Rhythm Pharmaceuticals, Inc. (RYTM)
100.71
-4.47
(-4.25%)
USD |
NASDAQ |
Dec 09, 16:00
100.66
-0.05
(-0.05%)
After-Hours: 20:00
Rhythm Pharmaceuticals Market Cap: 6.721B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 148.09B |
| Terns Pharmaceuticals, Inc. | 3.835B |
| Altimmune, Inc. | 574.40M |
| Viking Therapeutics, Inc. | 4.214B |
| Cidara Therapeutics, Inc. | 6.927B |
Market Cap Related Metrics
| PS Ratio | 36.77 |
| Price to Book Value | 45.16 |
| Price | 100.71 |
| Earnings Yield | -3.08% |